Marizela Kulisic holds PhD in molecular biology with two post-docs. Last 7 years she has been working for the National Center of Genetics in Luxembourg in the area of molecular diagnostics of different hereditary diseases. Marizela’s focuses are newborn screening, and non-invasive prenatal testing (NIPT). She was involved in implementing newborn screening for cystic fibrosis and SMA in Luxembourg.

Marizela has a broad experience from fundamental research, biotech industry and molecular genetics. She started her career by doing pre and post-natal molecular diagnostics and IVF. After finishing her PhD, she did two post-docs – first one at King’s College London in the area of iron metabolism and the second one at Luxembourg Institute of Health in the area of cardiovascular diseases. From 2012 to 2017, she has been leading the European Demo and Training Centre of an American biotech company (Wafergen Biosystems, now part of Takara Bio) where she gained a lot of experience in the next-generation sequencing (NGS) and single cell sequencing. Since 2017, she has been working for the National Health Laboratory in Luxembourg (LNS) in implementation and interpretation of different genetic tests.